Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 12;21(1):2.
doi: 10.1007/s11910-020-01087-7.

Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases

Alessandro Galgani  1 , Francesco Lombardo  2 , Daniele Della Latta  3 , Nicola Martini  3 , Ubaldo Bonuccelli  1 , Francesco Fornai  4   5 , Filippo Sean Giorgi  6   7
Affiliations
Review

Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases

Alessandro Galgani et al. Curr Neurol Neurosci Rep. .

Abstract

Purpose of review: Locus coeruleus (LC) is the main noradrenergic nucleus of the brain, and its degeneration is considered to be key in the pathogenesis of neurodegenerative diseases. In the last 15 years,MRI has been used to assess LC in vivo, both in healthy subjects and in patients suffering from neurological disorders. In this review, we summarize the main findings of LC-MRI studies, interpreting them in light of preclinical and histopathological data, and discussing its potential role as diagnostic and experimental tool.

Recent findings: LC-MRI findings were largely in agreement with neuropathological evidences; LC signal showed to be not significantly affected during normal aging and to correlate with cognitive performances. On the contrary, a marked reduction of LC signal was observed in patients suffering from neurodegenerative disorders, with specific features. LC-MRI is a promising tool, which may be used in the future to explore LC pathophysiology as well as an early biomarker for degenerative diseases.

Keywords: Alzheimer’s disease; Locus coeruleus; Magnetic resonance imaging; Neuromelanin; Noradrenaline; Parkinson’s disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci. 2009;10(3):211–223. - PubMed
    1. Berridge CW, Schmeichel BE, España RA. Noradrenergic modulation of wakefulness/arousal. Sleep Med Rev. 2012;16:187–197. - PMC - PubMed
    1. Giorgi FS, Saccaro LF, Galgani A, Busceti CL, Biagioni F, Frati A, Fornai F. The role of locus coeruleus in neuroinflammation occurring in Alzheimer’s disease. Brain Res Bull. 2019;153:47–58. - PubMed
    1. Lecrux C, Hamel E. Neuronal networks and mediators of cortical neurovascular coupling responses in normal and altered brain states. Philos Trans R Soc Lond B Biol Sci [Internet]. 2016;371(1705):20150350. https://pubmed.ncbi.nlm.nih.gov/27574304. - PMC - PubMed
    1. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci. 2005;28(1):403–450. - PubMed

Publication types